Aap Implantate AGAAQX:GER

1.50
0.049 / 3.38%
100
34.83 %
0.5345
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 27 2016 09:10 BST.

About the company

30.57m-3.44m--218
Revenue in EUR (TTM)Net income in EURIncorporatedEmployees
IndustryHealth Care Equipment & ServicesLocation
Aap Implantate AG
Lorenzweg 5
BERLIN12099
Germany
DEU
Phone+49 30750190Fax+49 3 075019111Websitehttp://www.aap.de/
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics, and offers a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Mergers & acquisitions

There are no recent mergers or acquisitions for Aap Implantate AG.
Data delayed at least 15 minutes, as of May 27 2016 09:10 BST.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
UMS United Medical Systems Intl. AG
0-1.59m16.25m1--0.9771756.40---0.375-0.3750.003.500.00----0.00-4.5329---4.5672--------------0.00--------------
Medisana AG
59.30m66.64k25.66m157385.375.2736.450.43280.00710.00716.330.51991.652.906.48377,7150.1077-5.59970.6723-19.126626.4024.940.0651-3.97670.54851.130.4424--15.255.09103.44---31.5006--
ifa systems AG
7.33m1.61m27.50m8218.071.4810.833.750.55330.55332.556.750.3414.504.7289,390.247.487.267.928.0076.9671.6621.9915.002.34122.100.014420.903.946.0747.4614.78---2.331
aap Implantate AG
30.57m-3.44m44.71m218--1.03--1.46-0.1119-0.11220.9951.410.49990.86533.40140,853-5.61811.06-6.66931.3368.2776.81-11.23832.191.76-10.82230.18520.007.21-2.8309-148.9536--4.83--
Geratherm Medical AG
21.67m2.37m59.70m19425.202.6218.572.760.47860.47864.384.600.72961.196.10--7.595.368.946.2062.6557.9710.418.143.71--0.105688.2015.364.3860.56-0.0762-8.75764.56
MagForce AG
1.29m-4.33m117.81m22--4.72--91.09-0.1571-0.15710.04890.97390.0535--4.4558,790.91-17.9033-26.2407-18.7724-78.308-69.2307-5,024.049-334.4665-5,798.4369.27--0.00------38.05------
Windeln De AG
178.60m-30.40m144.85m553--1.24--0.811-1.2067-1.20677.474.46------322,969--------26.38---17.0233--2.86-9.44980.0777--76.27---209.3925------
Pulsion Medical Systems SE
31.67m5.41m202.21m9037.437.3029.736.380.65490.65493.843.360.97111.793.88351,88316.5820.1521.2426.3063.6666.9517.0718.511.7915.740.0033.223.632.39-45.390463.48----
Data as of May 29 2016. Currency figures normalised to Aap Implantate AG's reporting currency: Euro EUR.

Institutional shareholders

There are no institutional shareholders for Aap Implantate AG.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.